Free Trial

Denali Therapeutics (DNLI) SEC Filings & 10K Form

Denali Therapeutics logo
$14.23 -0.12 (-0.84%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$14.56 +0.33 (+2.32%)
As of 08/7/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Denali Therapeutics SEC Filings

DateFilerForm TypeView
07/11/2025
4:13 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025
7:04 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
3:53 PM
BAKER JULIAN (Reporting)
Denali Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2025
3:57 PM
667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Denali Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2025
3:23 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:25 PM
Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:26 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:05 PM
Denali Therapeutics (Filer)
Form DEF 14A
04/17/2025
3:06 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/17/2025
3:07 PM
Denali Therapeutics (Filer)
Form ARS
04/17/2025
2:05 PM
BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
04/02/2025
7:02 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:26 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
Denali Therapeutics (Filer)
Form S-3ASR
02/27/2025
3:12 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM
Denali Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
1:14 PM
Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
9:52 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:03 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:23 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:25 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:01 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:03 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:06 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:08 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:10 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:12 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:14 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
5:56 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:57 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:59 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:17 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:18 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:44 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s national nightmare is here (Ad)

Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.

Watch the National Emergency broadcast here
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
10/18/2024
3:19 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
3:37 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:25 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:25 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:26 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:15 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:16 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:40 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:42 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:27 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
12:18 PM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
08/15/2024
3:10 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:36 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:37 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DNLI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners